Our findings demonstrated that the anti-histaminic drugs CTZ and LOR may target PI3K/p-Akt/Nrf2 as an underlying mechanism for their ability to treat ulcerative colitis in rats produced by acetic acid. Here, AKT1 is linked to ulcerative colitis.